Answers are grounded in this paper and cite their sources.
In a study of two groups of healthy males matched for age, smoking habits, and duration of follow-up, but differing in the rapidity of decline of FEV1 and/or vital capacity (VC), we measured lung volumes before and after bronchodilator inhalation, forced expiratory flows, diffusion capacity for CO (DLCO), and total respiratory impedance. A discriminant analysis showed that the separation between the two groups was achieved best by DLCO, weight, and FEV1/VC among the smokers and by body height and DLCO among the nonsmokers. The fact that DLCO turns out to discriminate between people with a rapid and a normal spirographic decline in the present group points to the possibility of using this measurement, in combination with FEV1/VC and weight, as a predictor of rapid decline of lung function in middle-aged healthy male smokers.
No takes yet. Share an insight, caveat, or question.
Cauberghs et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: